: The dependence of the release field on the intermediate layer material. Figure S2 : Atomic force microscopy. Figure S3 : Fourier transform infra-red studies. Figure S4 : Mass spectrometry. Figure S5 : XRD analysis. Table S1 . The field release dependence on the field, frequency, and the treatment duration. Table S2 . Trypan-Blue cell viability assay. Table S3 . Size and Zeta-potential measurements. Figure S1: The dependence of the release field on the intermediate layer material. The four charts show the release kinetics (field strength and frequency dependence on the field treatment duration) for (A) uncoated MENs, (B) GMO-MENs, (C) Tween20-MENs, and (D) EDC-MENs. Here EDC stands for 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Figure S2 : Atomic force microscopy. Topography and phase-contrast atomic force microscopy (AFM) images of (A and B) GMO-MENs only, (C and D) GMO-MENs loaded with PTX, (E and F) GMO-MENs after the 36-Oe 1000-Hz field-triggered release, and (G and H) PTX only.
SUPPLEMENTARY INFORMATION TABLE LEGENDS

Supplementary Information Figures
The imaging was performed in Tapping Mode TM using Nanoscope IIIa Multimode AFM (Veeco Metrology, CA). The samples were specially prepared for the imaging by dispersing desired MENs on the silicon wafer surface (1 × 1 cm 2 ). To achieve uniform dispersion of MENs, the nanoparticles of choice were first mixed in chloroform solution (1mg of particles in 600 μl of chloroform). Then, 100 μl of this solution was mixed with 200 μl of isopropanol and the solution was set to 3500-rpm centrifugation for 3 minutes. Finally, the obtained pellet of MENs was dissolved in 200 μl of Chloroform and 20 μl of this solution was placed on a silicon wafer and then dried at room temperature overnight. The silicon wafer containing the desired MENs were glued on to a metallic sample puck and mounted on the AFM stage. All the images were performed in 256 × 256 scan resolution at a scan rate of 0.5 Hz at a 40-nm Z-scale and a 60 0 -Phase angle. Tables   Table S1: The field release dependence on the field, frequency, and the treatment duration. The table shows the percentage of the field-triggered released PTX at different combinations of the magnetic field strength (12, 44, and 66 Oe) and frequency (0, 100, and 1000 Hz) and the treatment duration (1, 5, 10, 60, and 120 minutes). Table S3 . Size and Zeta-potential measurements. The Malvern Zeta-sizer was used to measures size and Zeta-potential of the MENs, GMO-MENs, HER2-GMO-MENs, and PTX-GMOMENs (n=3). Concentration of the nanoparticles used for the measurements was 500ug/ml of D.I water. Note: The measurements represented are the average of three independent measurements.
Supplementary Information
Field Strength
Type of measurement Type of Particles
MENs GMO-MENs HER2-GMOMENs PTX-GMOMENs Size (nm)
28.6 ± 7.5 30.9 ± 8.6 43.0 ± 3.6 44 ± 6.6
Zeta-Potential (mV) -45.0 ± 1.7 -41.6 ± 0.3 -26.3 ± 0.4 -40.7 ± 0.1
